newsfilter
← Latest News
GlobeNewswire·

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

IRVINE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced that Steve Perrin, Ph.D., President and Chief Scientific Officer, will participate in a plenary